logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Prometheus Laboratories Inc.


USPTO Granted Patents = 22

% Expired Patents = 13.6



Trademarks = 21

Forward Citations = 197

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Sharat Singh (7 out of 100 patents)

silverMedal Bruce P Neri (4 out of 40 patents)

bronzeMedal Thierry Dervieux (3 out of 11 patents)

4.  Anjali Jain (3 out of 7 patents)

5.  Venkateswarlu Kondragunta (3 out of 6 patents)

6.  Esther H Oh (3 out of 3 patents)

7.  Stephan R Targan (2 out of 53 patents)

8.  Nicholas Hoe (2 out of 3 patents)

9.  Steve Lockton (2 out of 3 patents)

10.  Scott Hauenstein (2 out of 6 patents)

11.  Linda Ohrmund (2 out of 10 patents)

12.  Michael Hale (2 out of 10 patents)

13.  Jeanne Harvey (2 out of 10 patents)

14.  Augusto Lois (2 out of 5 patents)

15.  Paul Barstad (2 out of 2 patents)


22 patents:

1. 12485171 - Methods of disease activity profiling for personalized therapy management (2025-12-02),
2. 12422432 - Methods for assessing mucosal healing in inflammatory bowel disease patients (2025-09-23),
3. 11846642 - Indirect homogeneous mobility shift assays for the detection of biologics in patient samples (2023-12-19),
4. 11796541 - Methods for assessing mucosal healing in ulcerative colitis disease patients (2023-10-24),
5. 11435347 - Methods for prediction of anti-TNF α drug levels and autoantibody formation (2022-09-06),
6. 11160863 - Methods of disease activity profiling for personalized therapy management (2021-11-02),
7. 8163499 - Drug selection for breast cancer therapy using antibody-based arrays (2012-04-24),
8. 8114616 - Methods for diagnosing irritable bowel syndrome (2012-02-14),
9. 7943328 - Method and system for assisting in diagnosing irritable bowel syndrome (2011-05-17),
10. 7908091 - Methods of predicting and monitoring tyrosine kinase inhibitor therapy (2011-03-15),
11. 7873479 - Methods of diagnosing inflammatory bowel disease (2011-01-18),
12. 7759079 - Methods of diagnosing inflammatory bowel disease (2010-07-20),
13. 7695908 - Methods for predicting methotrexate polyglutamate levels using pharmacogenetics (2010-04-13),
14. 7670764 - Methods of diagnosing tissue fibrosis (2010-03-02),
15. 7582282 - Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics (2009-09-01),
Company Overview
Prometheus Laboratories Inc., based in San Diego, CA, specializes in developing and manufacturing innovative diagnostic solutions and therapeutic products. The company focuses on personalized medicine, particularly in the fields of gastrointestinal and autoimmune diseases. Prometheus leverages advanced technologies to enhance patient care through precise diagnostics and targeted therapies, aiming to improve health outcomes and streamline treatment processes in the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#273 in San Diego, CA

#3,582 in California

#15,021 in US

#28,749 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Prometheus Laboratories Inc.

Forward Citations = 197

36 inventors:

goldMedal Sharat Singh (7 out of 100 patents)

silverMedal Bruce P Neri (4 out of 40 patents)

bronzeMedal Thierry Dervieux (3 out of 11 patents)

4.  Anjali Jain (3 out of 7 patents)

5.  Venkateswarlu Kondragunta (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prometheus Laboratories Inc.. Retrieved from https://idiyas.com/company/prometheus-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…